Literature DB >> 6121406

Alteration of lymphoid cells in AKR mice by treatment with monoclonal antibody against Thy-1 antigen.

M R Tam, I D Bernstein, R C Nowinski.   

Abstract

AKR/J mice treated with high levels of monoclonal anti-Thy-1.1 antibody and C' remained healthy without apparent side effects. Examination of the lymphatic organs of these mice demonstrated a selective depletion of T cells in lymph nodes and spleen. Following cessation of treatment of the levels of anti-Thy-1.1 antibody in the circulation fell and the peripheral lymphatic organs gradually became repopulated with T cells. Depletion occurred in lymph nodes whether or not C' was infused along with the antibody. Although the thymocytes of these mice were coated with anti-Thy-1.1 antibody they were not eliminated by the treatment. The elimination of peripheral but not thymic T cells suggests either a thymic barrier to the penetration of cofactors (possibly antibody-dependent effector cells) or that antibody acts by interfering with the normal traffic of peripheral T cells which normally "home" to the lymph nodes and spleen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6121406     DOI: 10.1097/00007890-198203000-00012

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  Analysis of the function of L3T4+ T cells by in vivo treatment with monoclonal antibody to L3T4.

Authors:  D Wofsy; W E Seaman
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

2.  Host defense against cholera toxin is strongly CD4+ T cell dependent.

Authors:  E Hörnqvist; T J Goldschmidt; R Holmdahl; N Lycke
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

3.  Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen.

Authors:  Y Sharabi; D H Sachs
Journal:  J Exp Med       Date:  1989-02-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.